Redsense Medical AB (publ) (XSAT:REDS)
2.700
+0.020 (0.75%)
At close: May 19, 2026
Redsense Medical AB Company Description
Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia.
It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow.
The company was founded in 2000 and is headquartered in Halmstad, Sweden.
Redsense Medical AB (publ)
| Country | Sweden |
| Founded | 2000 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 6 |
| CEO | Sebastien Bollue |
Contact Details
Address: Storgatan 36 Halmstad, 302 43 Sweden | |
| Phone | 46 35 10 60 30 |
| Website | redsensemedical.com |
Stock Details
| Ticker Symbol | REDS |
| Exchange | Spotlight Stock Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Sebastien Bollue | Chief Executive Officer |
| Peter Larsson | Chief Financial Officer |